Histone deacetylases (HDACs) control gene expression by deacetylating histones and nonhistone proteins. HDAC inhibitors (HDACi) are powerful anticancer drugs that exert anti-inflammatory and immunomodulatory activities. We recently reported a proof-of-concept study demonstrating that HDACi increase susceptibility to bacterial infections in vivo. Yet, still little is known about the effects of HDACi on antimicrobial innate immune defenses. Here we show that HDACi belonging to different chemical classes inhibit at multiple levels the response of macrophages to bacterial infection. HDACi reduce the phagocytosis and the killing of Escherichia coli and Staphylococcus aureus by macrophages. In line with these findings, HDACi decrease the expression of phagocytic receptors and inhibit bacteria-induced production of reactive oxygen and nitrogen species by macrophages. Consistently, HDACi impair the expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits and inducible nitric oxide synthase. These data indicate that HDACi have a strong impact on critical antimicrobial defense mechanisms in macrophages.
Histone deacetylases (HDACs) control gene expression by deacetylating histones and nonhistone proteins. HDAC inhibitors (HDACi) are powerful anticancer drugs that exert anti-inflammatory and immunomodulatory activities. We recently reported a proof-of-concept study demonstrating that HDACi increase susceptibility to bacterial infections in vivo. Yet, still little is known about the effects of HDACi on antimicrobial innate immune defenses. Here we show that HDACi belonging to different chemical classes inhibit at multiple levels the response of macrophages to bacterial infection. HDACi reduce the phagocytosis and the killing of Escherichia coli and Staphylococcus aureus by macrophages. In line with these findings, HDACi decrease the expression of phagocytic receptors and inhibit bacteria-induced production of reactive oxygen and nitrogen species by macrophages. Consistently, HDACi impair the expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits and inducible nitric oxide synthase. These data indicate that HDACi have a strong impact on critical antimicrobial defense mechanisms in macrophages.
The innate immune system plays a crucial role in host defenses against invasive microorganisms. Professional phagocytes are key sentinel cells of the innate immune system. Pathogen recognition relies on the capacity of phagocytes to sense microbial molecular motifs (eg, lipopolysaccharide, peptidoglycan, lipopeptides, mannans, glucans, flagellin, and nucleic acids) via patternrecognition receptors comprising Toll-like receptors (TLRs), nucleotide-binding oligomerization domainlike receptors (NLRs), retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), C-type lectin receptors (CLRs), and scavenger receptors [1] . The engagement of phagocytic receptors, either through a direct interaction with microbial motifs or through the recognition of opsonized infectious agents, stimulates the engulfment and the delivery of the pathogen to the phagosome. Phagosome maturation by fission and fusion with endosomes and lysosomes generates the phagolysosome that provides a powerful microbicidal microenvironment, usually resulting in efficient microbial killing [2, 3] . The release of proinflammatory cytokines during an infection stimulates the production of powerful phagocyte activating molecules like interferon c (IFNc).
Reversible acetylation of the e amino groups of lysine residues from histones and nonhistone proteins (such as a-tubulin, steroid receptors, HSP90, and regulators of nuclear import and transcription) is controlled by histone acetyltransferases and histone deacetylases (HDACs). Generally, acetylated histones are associated with active gene transcription, whereas deacetylated histones are associated with transcription repression [4] [5] [6] . The 18 mammal HDACs have been classified into class I (HDAC1-3 and 8), class IIa (HDAC4, 5, 7 and 9), class IIb (HDAC6 and 10), class III (SIRT1-7), and class IV (HDAC11) HDACs [4, 7] . Small-molecule inhibitors of class I, II, and IV HDACs were originally identified for their potential to induce cellular differentiation, growth arrest, and apoptosis of transformed cells. HDACi targeting class I and II HDACs have been reported to counteract cancer development by reducing tumor angiogenesis, metastasis, and invasion and antitumor immunity [4] [5] [6] .
Besides their anticancer properties, HDACi exert immunomodulatory activities that have been exploited for the treatment of inflammatory and autoimmune disease [8] . Recently, we reported that HDACi interfere with the response of innate immune cells stimulated with TLR agonists and increase the mortality of mice to microbial sepsis [9] . Yet, whether HDACi impair the phagocytosis and the killing of bacteria by phagocytes remains unknown. To more deeply characterize the influence of HDACi on innate immune responses, we investigated whether HDACi have an impact on key antibacterial defense mechanisms of macrophages. We report that HDACi reduce the expression of phagocytic and opsonophagocytic receptors and inhibit the phagocytosis of Escherichia coli and Staphylococcus aureus, 2 of the most common infectious agents, by macrophages. Moreover, HDACi impair the generation of reactive oxygen and nitrogen species by macrophages infected with bacteria, resulting in a marked reduction of bacterial killing.
MATERIALS AND METHODS

Cells and Reagents
Animal procedures were approved by the Office Vétérinaire du Canton de Vaud (authorizations n°876.6) and performed according to institution guidelines for animal experiments. We purchased 8-to 10-week-old female BALB/c mice from Charles River Laboratories . We obtained mouse bone marrow-derived macrophages (BMDMs) and thioglycolate-elicited macrophages as previously described [10, 11] . RAW 264.7 macrophages were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium containing 2 mmol/L glutamine and 10% fetal calf serum (FCS) [12] . E. coli O18:K1:H7 (E. coli) and S. aureus AW7 (S. aureus) are clinical isolates obtained from septic patients hospitalized at the Centre Hospitalier Universitaire Vaudois. We purchased trichostatin A (TSA) and valproic acid (VPA) from Sigma-Aldrich, Salmonella minnesota Ultra Pure lipopolysaccharide (LPS) from List Biologicals Laboratories , and IFNc from R&D Systems. The concentrations of TSA (dissolved in ethanol) and VPA (dissolved in phosphate-buffered saline [PBS]) used in this study were selected based on previous publications [13] [14] [15] [16] [17] [18] and did not affect the viability (Trypan blue staining and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide [MTT] Cell Proliferation and Viability Assay) of BMDMs ($ 85% cell recovery after 18 hours of culture with 20-40 nmol/ L TSA and 1-2 mmol/L VPA with or without bacteria; n 5 6-9 determinations; P . .5 for all conditions). Ethanol and PBS vehicle controls were performed in each experiment. For simplicity only 1 set of data is presented in each ( Figures 2, 4 , 5, and 6).
Assay for Bacterial Uptake and Bacterial Killing E. coli and S. aureus were grown overnight at 37°C in tryptic soy broth (BD Biosciences), washed in PBS, and adjusted to 10 7 colony-forming units (CFU)/mL in RPMI medium containing 10% FCS. BMDMs (4 3 10 5 cells in 24-well cell-culture plates, Costar) were treated with TSA or VPA for 18 hours. Medium was changed and cells were incubated for 1 hour with bacteria at a multiplicity of infection of 20 bacteria per macrophage. Nonadherent bacteria were removed by washing with PBS. Extracellular bacteria were killed by a 30-minute exposure to either 100 lg/mL of gentamicin (E. coli) or 10 lg/mL of lysostaphin (S. aureus). We washed and lysed BMDMs. We plated serial dilutions of cell lysates on agar plates and enumerated colonies to calculate the number of phagocytosed bacteria. In parallel wells, BMDMs were treated as previously except that, after 30 minutes of incubation with antibiotics, cells were washed and incubated for a further 24 hours in culture medium containing 20 lg/mL gentamicin or 10 lg/mL lysostaphin. Bacteria were enumerated and results expressed as percent changes in bacterial counts using the following formula: (count after 24 hours/count after 1 hour) 3 100. Of note, neither TSA nor VPA at the concentrations used in these assays were toxic for bacteria.
RNA Analysis by Quantitative Real-Time Polymerase Chain Reaction
RNA was isolated using the RNeasy kit (Qiagen). Reverse transcription was performed using the ImProm II RT System kit (Promega). Quantitative real-time polymerase chain reaction (PCR) was performed with a 7500 Fast Real-Time PCR System using the Power SYBR Green PCR Master Mix (Applied Biosystems) and primer pairs (Supplementary Table 1 ) as previously described [19] . We tested samples in triplicate. For each measurement, we processed in parallel a standard made of successive dilutions of a reference complementary DNA. The relative expression levels of NADPH oxidase subunits and inducible nitric oxide synthase (iNOS) were reported to the relative expression of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and expressed in arbitrary units (AU). The expression of phagocytic receptors and TLRs was calculated with the comparative Ct (DDCt) method . The expression of the target gene was first normalized to the endogenous control (Gapdh) and then to that of a calibrator (ie, data obtained from cells cultured with vehicle set at 1 
Flow Cytometric Analysis
BMDMs cultured for 18 hours with TSA (40 nmol/L) and VPA (2 mmol/L) were incubated 30 minutes at 4°C in PBS containing 5% FCS, 5 mM ethylenediaminetetraacetic acid (EDTA), 2.4G2 monoclonal antibody, and monoclonal antibodies specific for macrophage scavenger receptor 1 (Msr1/CD204), CD11c, CD14, and major histocompatibility complex II (MHC-II) [20] . Acquisition and analysis were performed using a FACSCalibur (BD Biosciences) and FlowJo 8.5.3 software (FlowJow).
Analysis of Oxidative Burst Using the Dichlorofluorescein Diacetate Fluorescence Assay
BMDMs (4 3 10 5 cells in 24-well cell-culture plates) were cultured as previously described [21] and incubated for 18 hours with TSA and VPA. Dichlorofluorescein diacetate (DCFDA) (20 lmol/L, Sigma-Aldrich) was added to the cultures followed 15 minutes later by bacteria (5 3 10 8 CFU/mL). After 30 minutes, cell fluorescence was measured by flow cytometry.
Western Blot Analysis
Cell lysates were electrophoresed through polyacrylamide gels and transferred onto nitrocellulose membranes as previously described [12] . Membranes were incubated with antibodies directed against iNOS (BD Biosciences), p47 phox (Santa Cruz) and tubulin (Sigma). After washing, membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (Pierce). Signals were revealed using the ECL Western blotting analysis system (GE Healthcare).
Nitrite/Nitrate Measurements
BMDMs (10 5 cells in 96-well cell-culture plates) were preincubated for 1 hour with TSA and VPA and stimulated with LPS (100 ng/mL), IFNc (100 U/mL), E. coli (10 8 CFU/mL), and S. aureus (10 8 CFU/mL). Cell-culture supernatants were collected after 24 hours. The concentrations of nitrite/nitrate were measured using the Griess reagent.
Statistics
Statistical analyses were performed using PRISM (GraphPad Software). Comparisons between the different groups were performed by analysis of variance and appropriate post hoc analyses. P values are 2-sided, and values of , .05 were considered to indicate statistical significance.
RESULTS
HDACi Inhibit Bacterial Phagocytosis by Macrophages
We recently reported that HDACi impair host defenses to bacterial infection in vivo [9] . Whether HDACi impact the phagocytosis and the killing of bacteria is currently unknown.
To fill this gap, we first analyzed the phagocytosis of gramnegative (E. coli) and gram-positive (S. aureus) bacteria by BMDMs pretreated with 2 chemically unrelated HDACi: TSA, a hydroxamate widely used as a prototypical broad-spectrum HDACi, and VPA, a clinically relevant short fatty acid. The dose and duration of treatment with TSA and VPA were in the range of those used in cancer preclinical studies or measured in patients enrolled in cancer clinical trials (VPA) (see for example [13] [14] [15] [16] [17] [18] ). We evaluated phagocytosis after 1 hour of contact between bacteria and macrophages. As shown in Figure 1 , HDACi dose dependently reduced the number of E. coli (2-to 4-fold; P , .05) and S. aureus (1.5-to 2-fold; P , .05) phagocytosed by BMDMs.
HDACi Impair the Expression of Phagocytic Receptors
Macrophages express phagocytic scavenger receptors, including macrophage scavenger receptor 1 (Msr1/SR-AI/CD204), CD14, CD36, and C-type lectins such as Dectin-1 (encoded by Clec7a) that mediate the recognition of microbial ligands expressed at the surface of pathogens and initiate phagocytosis. Macrophages also express opsonic phagocytic receptors of the integrin family (integrin aX /Itgax/CD11c, integrin b2 /Itgb2/CD18, and integrin a5 / Itga5/CD49e) that facilitate the uptake of microorganisms coated with opsonins like the mannose-binding lectin, complement subcomponents, growth arrest specific 6, ficolins, and pentraxins [2, 22] . TSA and VPA reduced 2-to 10-fold Msr1, (Figure 2A) . TSA inhibited Itgb2 expression more efficiently than did VPA (2.4-fold with 40 nM TSA vs 1.4-fold with 2 mM VPA), whereas HDACi did not affect CD36, Itga5, or Itga6 expression. Flow cytometry analyses confirmed that TSA and VPA inhibited the expression of Msr1, CD11c and CD14 by BMDMs ( Figure 2B ). As a control of nonspecific broad inhibitory effects of HDACi, MHC-II expression was not affected by HDACi. All together, these data suggest that reduced expression of phagocytic receptors may contribute to impair the phagocytosis of E. coli and S. aureus in macrophages treated with HDACi.
HDACi Inhibit Bacterial Killing
TLRs play crucial roles in the sensing of invasive microorganisms and in transmitting signals involved in the maturation of phagosomes [23] . Interestingly, we observed that HDACi strongly reduced baseline expression of TLR1-7 and TLR9 in BMDMs ( Figure 2C ). Pathogen delivery to phagolysosomes usually results in effective microbial killing [2, 24] . In agreement, , 5% of E. coli and 25% of S. aureus phagocytosed by BMDMs were recovered 24 hours later in macrophages (P , .001; Figure 3 ). TSA and VPA reduced 5-fold and 3-fold E. coli and S. aureus killing, respectively (ie, increasing bacteria recovery to 25% and 75% of the ingested inoculum; P , .05). Thus, HDACi inhibit both the phagocytosis (Figure 1 ) and the killing (Figure 3 ) of bacteria by macrophages, in agreement with the observation that HDACi increased the susceptibility of mice to microbial infection [9] .
HDACi Interfere With the Generation of Reactive Oxygen Species
In response to microbial challenge, macrophages produce highly toxic reactive oxygen species (ROS) that contribute to pathogen destruction [25] . The generation of ROS in BMDMs was analyzed by flow cytometry using the cell permeable nonfluorescent dye 2#,7#-dichlorofluorescein diacetate (DCFDA) that is transformed on oxidation into the highly fluorescent DCF. E. coli and S. aureus strongly increased DCF fluorescence in BMDMs, which was inhibited 2-to 3-fold by TSA or VPA ( Figure 4A and 4B). HDACi also inhibited the production of ROS in BMDMs stimulated with phorbol myristate acetate (.10-fold reduction, data not shown) indicating that HDACi inhibit the oxidative burst induced by microbial and nonmicrobial stimuli.
In macrophages, ROS are generated during the respiratory burst through the action of the phagocytic NADPH oxidase, an enzymatic complex composed of 2 membrane-associated subunits (gp91 , and the Rac2 regulatory subunit [26, 27] . Cytokines, particularly IFNc, and microbial products released during an infection prime and amplify macrophage respiratory burst through the induction of NADPH oxidase subunits [21] . Real-time PCR and Western blot analyses revealed that TSA and VPA dose-dependently inhibited baseline expression of NADPH oxidase subunits and potently inhibited the upregulation of the catalytic gp91 phox and regulatory p47 phox subunits in LPS1IFNc-stimulated macrophages ( Figure 5 ). All together, these data provide compelling evidence that HDACi inhibit ROS production in macrophages.
HDACi Inhibit Nitric Oxide Production and iNos Gene Expression
Nitric oxide (NO) is produced during the nitrosative burst by iNOS and represents an important antimicrobial effector mechanism [25, 27] . TSA and VPA dose-dependently inhibited the production of NO by BMDMs stimulated with LPS1IFNc (50%-80% reduction; P , .05), in line with previous work showing that HDACi inhibit cytokine-induced NO release [28, 29] . More relevant for microbial infection, TSA and to a lesser extent VPA inhibited NO production induced by E. coli and S. aureus (50%-60% reduction using 20 nmol/L and 40 nmol/L TSA and 30%-35% reduction using 2 mmol/L VPA; P , .05) ( Figure 6A ). In agreement with these findings, real-time PCR and Western blot analyses demonstrated that TSA and VPA inhibited iNOS mRNA and protein expression in BMDMs ( Figure 6B and 6C) . Similar results were obtained using thioglycolate-elicited peritoneal and RAW 264.7 macrophages (data not shown). Taken together, these results suggest that HDACi impair NO production by BMDMs in response to bacterial challenge by interfering with iNOS expression.
DISCUSSION
In this study, we report for the first time to our knowledge that HDACi inhibit the phagocytosis and the killing of bacteria, the expression of phagocytic receptors, and the generation of oxidative and nitrosative bursts induced by bacteria in macrophages. These data extend our previous work demonstrating that HDACi interfere with cytokine production by macrophages and impair host defenses to bacterial infection [9] . The inhibition of E. coli and S. aureus phagocytosis by HDACi was associated with a reduced expression of phagocytic receptors, among which is Msr1 (scavenger receptor A1). Msr1 binds a wide range of microbial ligands and mediates . The number of bacteria recovered from macrophages after 24 hours was divided by the number of bacteria recovered after 1 hour and expressed in percentage using the formula (count after 24 hours/count after 1 hour) 3 100. Data are presented as mean 6 standard deviation (SD) of quadruplicate samples from 1 experiment representative of 2-3 experiments. *, .05 , P , .005; **, P , .005. Figure 4 . Histone deacetylase inhibitors interfere with the generation of reactive oxygen species. Mouse bone marrow-derived macrophages (BMDMs) were incubated with trichostatin A (TSA; 40 nmol/L) and valproic acid (VPA; 2 mmol/L) and exposed to Escherichia coli or Staphylococcus aureus as described in Material and Methods. A, The generation of reactive oxygen species (ROS) was quantified by flow cytometry by measuring dichlorofluorescein (DCF) diacetate oxidation into fluorescent DCF. B, Data are means 6 standard deviation (SD) of 2 independent determinations. P 5 .03 and .008 for E. coli and S. aureus vs control. *, P 5 .05; **, .05 , P , .005 vs E. coli-and S. aureus-treated cells.
nonopsonic phagocytosis of E. coli and S. aureus [30] . Moreover, Msr1 2/2 mice are more susceptible than wild-type mice to S. aureus infection [31] . Thus, HDACi-mediated inhibition of Msr1 expression may well help impair bacterial phagocytosis, although HDACi may target other phagocytic receptors such as the mannose receptor, MARCO, or CD14. Of note, HDACi decreased Dectin-1 expression in BMDMs.
Considering that Dectin-1 is a major receptor involved in the recognition of b-glucan, we speculate that HDACi may affect the phagocytosis of yeast. In line with this hypothesis, we observed that VPA increases mortality of mice infected with Candida albicans [9] . The ax and b2 integrin subunits contribute to the structure of complement receptor (CR) 3 and CR4 that mediate the recognition of opsonized microorganisms by phagocytes. b2 integrins play an important role in antimicrobial defenses as suggested by the observation that patients with leukocyte adhesion deficiency type I (LADI) syndrome (ie, patients deficient in functional b2 integrin) have defects in phagocytosis and are prone to bacterial infections [32] . All together, inhibition of the expression of ax and b2 integrins and scavenger and lectin receptors by HDACi support the contention that HDACi interfere with bacterial opsonic and nonopsonic phagocytosis.
HDACi powerfully inhibited the killing of E. coli and S. aureus by macrophages. This observation is congruent with the fact that VPA treatment increased the proportion and the magnitude of bloodstream infections in mice infected with Klebsiella pneumoniae [9] . Reactive oxygen and nitrogen species are among the most deleterious components produced by phagocytes and implicated in the destruction of microorganisms [2, 24] . Deficiency in members of the NADPH oxidase complex or in iNOS, which control the generation of superoxide (O 2 2°) and nitric oxide (NO°) radicals, impair the killing of E. coli and S. aureus by innate immune cells and compromise mouse survival [33] [34] [35] [36] . Moreover, germ-line mutation in 1 of the components of NADPH oxidase complex results in chronic granulomatous disease characterized by recurrent bacterial and fungal infections and reduced life expectancy [25] . Inhibition of NADPH oxidase subunit and iNOS expression and of reactive oxygen and nitrogen species generation by HDACi likely represents an effective mechanism by which these drugs impair the killing of bacteria.
In agreement with the notion that phagocytosis is coupled with a proinflammatory cytokine response and with the observation that HDACi inhibit TLR expression, HDACi strongly impaired the secretion of cytokines and chemokines (TNF, IL-6, IL-12p40, and MIP-2a, data not shown) by macrophages infected with E. coli and S. aureus. These data expand on recent studies showing that HDACi inhibit cytokine production induced by cytokines and purified microbial products in innate immune cells [14, 15, 28, 37, 38] . Considering that proinflammatory mediators released during the course of an infection coordinate the development of innate and adaptive immunity, one may expect that HDACi interfere with the generation of pathogen-specific adaptive immune response.
HDACi have been reported to interfere with signaling pathways controlling the expression of genes particularly relevant for this study. Indeed, HDACi down-regulate the expression of PU.1 transcription factor [37, 39] , which regulates constitutive expression of HDACi-target genes encoding for integrins, scavenger receptors, TLR4, CD14, and p40, p47, and p67 NADPH oxidase subunits [20, 40] . Moreover, HDACi have been reported to interfere with the activation of mitogen-activated protein kinases, NF-jB, and AP-1, which control inflammatory and antimicrobial host responses [15, 41] . HDACi also impair gene expression through chromatin modifications or aceytlationdependent recruitment of transcriptional repressors, albeit these mechanisms are less well characterized. For example, TSA inhibits the expression of the proinflammatory cytokine macrophage migration inhibitory factor through a local deacetylation of migration inhibitory factor-promoter-associated histones impairing the recruitment of the basal transcriptional machinery [42, 43] . Finally, we have recently shown that TSA inhibits macrophage response to LPS stimulation by inducing the expression of Mi-2b and the activity of the Mi-2/NuRD transcriptional repressor complex [9] .
HDACi have been used to treat inflammatory diseases in mouse models [8] . Abundant preclinical and clinical studies indicate that interfering with critical mediators of innate or adaptive immunity increases the risk of infections. Thus, one may question whether HDACi might affect natural host defenses in patients, as could be anticipated from the powerful immunomodulatory and anti-inflammatory activities of HDACi in vivo [8] and the increased susceptibility to bacterial and fungal infections of mice treated with HDACi [9] . Patients treated with HDACi (suberoylanilide hydroxamic acid, MS-275, valproate, and ITF2357) in phase I and II clinical trials have developed episodes of severe infection even in the absence of treatmentinduced neutropenia [44] [45] [46] [47] [48] [49] , suggesting the need to monitor the immune status and susceptibility to infection of patients treated with HDACi, especially immunosuppressed cancer patients [4] [5] [6] 50] .
In summary, this study demonstrates that HDACi impair the capacity of macrophages to ingest and destroy gram-positive and gram-negative bacteria. The fact that HDACi impede the expression of phagocytic receptors, the generation of oxygenand nitrogen-reactive species, and the release of proinflammatory cytokines provide a plausible mechanism whereby HDACi negatively impact critical antimicrobial functions of innate immune cells and increase the susceptibility of mice to bacterial and fungal infection [9] .
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